知镜 Cognispect · 医学文献与研究工作台

Early prediction of metastatic insulinoma using tumor size and biochemical markers: a retrospective cohort study.

Mathew A, Freudenberg B, Wichert M, Weber F, Schaarschmidt BM, Braegelmann J, Kersting D, Fuhrer D, Lahner H.
Frontiers in endocrinology · 2026-08-25 · PMID 42713095

文献摘要

Introduction Insulinomas are rare functional pancreatic neuroendocrine tumors. Metastasis is found in up to 15% of patients and is difficult to predict at diagnosis. Methods We retrospectively analyzed 64 patients (56.2% female, median age 49 years) with biochemically confirmed insulinoma treated at a European Neuroendocrine Tumor Society Center of Excellence between 2010 and 2024, assessing clinical characteristics, tumor biology, diagnostics, treatments and survival (median follow-up 23 months) . Results Metastasis was present in 27% of cases (17/64). Metastatic insulinomas had significantly larger primary tumors (median 32 vs. 15 mm, p Discussion Our analysis highlights relevant clinical and biological distinctions between non-metastatic and metastatic insulinomas. Based on three diagnostic parameters, we propose a predictive model for early risk stratification to guide staging intensity and follow-up in insulinoma management.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。